newsfilter
← Latest News
GlobeNewswire·

Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference

EQ

LA JOLLA, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new